Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
CONCLUSIONS: Boosters provide high level of protection against severe COVID-19 outcomes and deaths with newer omicron sub-lineages. Booster campaigns should focus on improving coverage utilising all available vaccines to ensure optimal protection.PMID:37880062 | DOI:10.1016/j.jmii.2023.10.001 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 25, 2023 Category: Microbiology Authors: Kannikar Intawong Suwat Chariyalertsak Kittipan Chalom Thanachol Wonghirundecha Woravut Kowatcharakul Aksara Thongprachum Narain Chotirosniramit Kajohnsak Noppakun Krit Khwanngern Worachet Teacharak Prapon Piamanant Pimpinan Khammawan Sopon Iamsirithaworn Source Type: research

Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
CONCLUSIONS: Boosters provide high level of protection against severe COVID-19 outcomes and deaths with newer omicron sub-lineages. Booster campaigns should focus on improving coverage utilising all available vaccines to ensure optimal protection.PMID:37880062 | DOI:10.1016/j.jmii.2023.10.001 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 25, 2023 Category: Microbiology Authors: Kannikar Intawong Suwat Chariyalertsak Kittipan Chalom Thanachol Wonghirundecha Woravut Kowatcharakul Aksara Thongprachum Narain Chotirosniramit Kajohnsak Noppakun Krit Khwanngern Worachet Teacharak Prapon Piamanant Pimpinan Khammawan Sopon Iamsirithaworn Source Type: research

Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
CONCLUSIONS: Boosters provide high level of protection against severe COVID-19 outcomes and deaths with newer omicron sub-lineages. Booster campaigns should focus on improving coverage utilising all available vaccines to ensure optimal protection.PMID:37880062 | DOI:10.1016/j.jmii.2023.10.001 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 25, 2023 Category: Microbiology Authors: Kannikar Intawong Suwat Chariyalertsak Kittipan Chalom Thanachol Wonghirundecha Woravut Kowatcharakul Aksara Thongprachum Narain Chotirosniramit Kajohnsak Noppakun Krit Khwanngern Worachet Teacharak Prapon Piamanant Pimpinan Khammawan Sopon Iamsirithaworn Source Type: research

Corrigendum to & lt;'Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials' & gt;[J Microbiol Immunol Infect 55 (1) (2022) 26-35]
J Microbiol Immunol Infect. 2023 Oct 17:S1684-1182(23)00194-9. doi: 10.1016/j.jmii.2023.10.003. Online ahead of print.NO ABSTRACTPMID:37858516 | DOI:10.1016/j.jmii.2023.10.003 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 20, 2023 Category: Microbiology Authors: Shao-Huan Lan Chih-Cheng Lai Shen-Peng Chang Chun-Chun Hsu Cheng-Hsin Chen Ya-Hui Wang Yueh Lan Huang Cheng-Yi Wang You-Shuei Lin Source Type: research

Corrigendum to & lt;'Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials' & gt;[J Microbiol Immunol Infect 55 (1) (2022) 26-35]
J Microbiol Immunol Infect. 2023 Oct 17:S1684-1182(23)00194-9. doi: 10.1016/j.jmii.2023.10.003. Online ahead of print.NO ABSTRACTPMID:37858516 | DOI:10.1016/j.jmii.2023.10.003 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 20, 2023 Category: Microbiology Authors: Shao-Huan Lan Chih-Cheng Lai Shen-Peng Chang Chun-Chun Hsu Cheng-Hsin Chen Ya-Hui Wang Yueh Lan Huang Cheng-Yi Wang You-Shuei Lin Source Type: research

Corrigendum to & lt;'Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials' & gt;[J Microbiol Immunol Infect 55 (1) (2022) 26-35]
J Microbiol Immunol Infect. 2023 Oct 17:S1684-1182(23)00194-9. doi: 10.1016/j.jmii.2023.10.003. Online ahead of print.NO ABSTRACTPMID:37858516 | DOI:10.1016/j.jmii.2023.10.003 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 20, 2023 Category: Microbiology Authors: Shao-Huan Lan Chih-Cheng Lai Shen-Peng Chang Chun-Chun Hsu Cheng-Hsin Chen Ya-Hui Wang Yueh Lan Huang Cheng-Yi Wang You-Shuei Lin Source Type: research

Corrigendum to & lt;'Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials' & gt;[J Microbiol Immunol Infect 55 (1) (2022) 26-35]
J Microbiol Immunol Infect. 2023 Oct 17:S1684-1182(23)00194-9. doi: 10.1016/j.jmii.2023.10.003. Online ahead of print.NO ABSTRACTPMID:37858516 | DOI:10.1016/j.jmii.2023.10.003 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 20, 2023 Category: Microbiology Authors: Shao-Huan Lan Chih-Cheng Lai Shen-Peng Chang Chun-Chun Hsu Cheng-Hsin Chen Ya-Hui Wang Yueh Lan Huang Cheng-Yi Wang You-Shuei Lin Source Type: research

Corrigendum to & lt;'Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials' & gt;[J Microbiol Immunol Infect 55 (1) (2022) 26-35]
J Microbiol Immunol Infect. 2023 Oct 17:S1684-1182(23)00194-9. doi: 10.1016/j.jmii.2023.10.003. Online ahead of print.NO ABSTRACTPMID:37858516 | DOI:10.1016/j.jmii.2023.10.003 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 20, 2023 Category: Microbiology Authors: Shao-Huan Lan Chih-Cheng Lai Shen-Peng Chang Chun-Chun Hsu Cheng-Hsin Chen Ya-Hui Wang Yueh Lan Huang Cheng-Yi Wang You-Shuei Lin Source Type: research

Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728]
J Microbiol Immunol Infect. 2023 Oct 12:S1684-1182(23)00193-7. doi: 10.1016/j.jmii.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37838594 | DOI:10.1016/j.jmii.2023.10.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 14, 2023 Category: Microbiology Authors: Ching-Yen Tsai Guan-Jhou Chen Chin-Shiang Tsai Bo-Huang Liou Chia-Jui Yang Hung-Chin Tsai Chi-Ying Lin Sung-Hsi Huang Kuan-Yin Lin Ning-Chi Wang Tun-Chieh Chen Chen-Hsiang Lee Chien-Ching Hung Taiwan HIV Study Group Source Type: research

Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728]
J Microbiol Immunol Infect. 2023 Oct 12:S1684-1182(23)00193-7. doi: 10.1016/j.jmii.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37838594 | DOI:10.1016/j.jmii.2023.10.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 14, 2023 Category: Microbiology Authors: Ching-Yen Tsai Guan-Jhou Chen Chin-Shiang Tsai Bo-Huang Liou Chia-Jui Yang Hung-Chin Tsai Chi-Ying Lin Sung-Hsi Huang Kuan-Yin Lin Ning-Chi Wang Tun-Chieh Chen Chen-Hsiang Lee Chien-Ching Hung Taiwan HIV Study Group Source Type: research

Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728]
J Microbiol Immunol Infect. 2023 Oct 12:S1684-1182(23)00193-7. doi: 10.1016/j.jmii.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37838594 | DOI:10.1016/j.jmii.2023.10.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 14, 2023 Category: Microbiology Authors: Ching-Yen Tsai Guan-Jhou Chen Chin-Shiang Tsai Bo-Huang Liou Chia-Jui Yang Hung-Chin Tsai Chi-Ying Lin Sung-Hsi Huang Kuan-Yin Lin Ning-Chi Wang Tun-Chieh Chen Chen-Hsiang Lee Chien-Ching Hung Taiwan HIV Study Group Source Type: research

Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728]
J Microbiol Immunol Infect. 2023 Oct 12:S1684-1182(23)00193-7. doi: 10.1016/j.jmii.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37838594 | DOI:10.1016/j.jmii.2023.10.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 14, 2023 Category: Microbiology Authors: Ching-Yen Tsai Guan-Jhou Chen Chin-Shiang Tsai Bo-Huang Liou Chia-Jui Yang Hung-Chin Tsai Chi-Ying Lin Sung-Hsi Huang Kuan-Yin Lin Ning-Chi Wang Tun-Chieh Chen Chen-Hsiang Lee Chien-Ching Hung Taiwan HIV Study Group Source Type: research

Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCV-coinfected patients who received direct-acting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728]
J Microbiol Immunol Infect. 2023 Oct 12:S1684-1182(23)00193-7. doi: 10.1016/j.jmii.2023.10.002. Online ahead of print.NO ABSTRACTPMID:37838594 | DOI:10.1016/j.jmii.2023.10.002 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 14, 2023 Category: Microbiology Authors: Ching-Yen Tsai Guan-Jhou Chen Chin-Shiang Tsai Bo-Huang Liou Chia-Jui Yang Hung-Chin Tsai Chi-Ying Lin Sung-Hsi Huang Kuan-Yin Lin Ning-Chi Wang Tun-Chieh Chen Chen-Hsiang Lee Chien-Ching Hung Taiwan HIV Study Group Source Type: research

Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism
CONCLUSIONS: This study provides a comprehensive analysis of the cardiovascular impact of the COVID-19 pandemic on individuals with PA. The findings underscore the increased risk of mortality, critical care, MACE, and MAKE among patients with PA and COVID-19. The study highlights the need for continued optimization of strategies for follow-up care for patients with PA after SARS-CoV-2 infections.PMID:37827953 | DOI:10.1016/j.jmii.2023.09.005 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 12, 2023 Category: Microbiology Authors: Vin-Cent Wu Jui-Yi Chen Yen-Hung Lin Cheng-Yi Wang Chih-Cheng Lai Source Type: research

Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism
CONCLUSIONS: This study provides a comprehensive analysis of the cardiovascular impact of the COVID-19 pandemic on individuals with PA. The findings underscore the increased risk of mortality, critical care, MACE, and MAKE among patients with PA and COVID-19. The study highlights the need for continued optimization of strategies for follow-up care for patients with PA after SARS-CoV-2 infections.PMID:37827953 | DOI:10.1016/j.jmii.2023.09.005 (Source: Journal of Microbiology, Immunology, and Infection)
Source: Journal of Microbiology, Immunology, and Infection - October 12, 2023 Category: Microbiology Authors: Vin-Cent Wu Jui-Yi Chen Yen-Hung Lin Cheng-Yi Wang Chih-Cheng Lai Source Type: research